We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Abingdon Health Limited (ABDX) ORD GBP0.00025

Sell:9.50p Buy:10.00p 0 Change: No change
Market closed Prices as at close on 3 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.50p
Buy:10.00p
Change: No change
Market closed Prices as at close on 3 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:9.50p
Buy:10.00p
Change: No change
Market closed Prices as at close on 3 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.

Contact details

Address:
York Biotech Campus, Sand Hutton
YORK
YO41 1LZ
United Kingdom
Telephone:
+44 (01904) 406050
Website:
https://www.abingdonhealth.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 14 March 2024 14/03/24
Trading Announcement 11 January 2024 11/01/24
AGM 15 December 2023 15/12/23
Final results 17 October 2023 17/10/23
Trading Announcement 06 July 2023 06/07/23

General stock information

EPIC:
ABDX
ISIN:
GB00BLF79J41
Market cap:
£11.87 million
Shares in issue:
121.72 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Christopher Yates
    Chief Executive Officer, Executive Director
  • Andrew Feather
    Interim Finance Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.